Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer
Condition: Ras-wildtype Colorectal CancerInterventions: Drug: Erythromycin; Drug: DoxycyclineSponsor: AIO-Studien-gGmbHActive, not recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Erythromycin | Research | Skin | Toxicology